Atlas Trials

Performance and Safety of IRIDIUM GARZE in Blepharitis or Blepharconjunctivitis Adjuvant Treatment

Clinical trial NCT07431385 · RECRUITING

Trial details

NCT number
NCT07431385
Sponsor
Fidia Farmaceutici s.p.a.
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
BlepharitisBlepharoconjunctivitis
Start date
2025-09-17
Primary completion
2026-03-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.